Ketamine Therapy: Types, Cost & How It Works (2026)

• By Sam Woolfe
• Medically approved by Abid Nazeer
• March 25, 2022May 5, 2026
• ketamine Ketamine Articles Ketamine dosage ketamine for depression ketamine infusion ketamine therapy ketamine treatment
• With 1 comment

Last reviewed and updated: May 4, 2026 — by Sam Woolfe, medically reviewed by Dr. Abid Nazeer, MD.

What Is Ketamine Therapy?

Ketamine therapy is the supervised, off-label medical use of ketamine — most commonly to treat depression that hasn’t responded to standard antidepressants, post-traumatic stress disorder (PTSD), chronic pain, and anxiety. The two FDA-recognized paths in the United States are Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression in 2019) and off-label IV/IM/oral ketamine prescribed under a clinician’s care. This guide covers what each path involves, what each typically costs, and how to evaluate whether ketamine therapy is right for you.

Ketamine was first synthesized in 1962 by Calvin Stevens at Wayne State University, and the FDA approved it as a general anesthetic in 1970. After more than a decade of routine adoption in operating rooms and emergency departments, clinical researchers in the early 2000s began documenting ketamine’s rapid antidepressant effect at sub-anesthetic doses. That research culminated in the 2019 FDA approval of Spravato (esketamine) for treatment-resistant depression — the first new mechanism for depression treatment approved in decades. Today, ketamine therapy spans Spravato (FDA-approved), off-label IV/IM/oral formulations prescribed by clinicians, and ketamine-assisted psychotherapy (KAP) protocols that pair the medication with structured talk therapy.

Ketamine Therapy Types Compared

Five protocols cover the bulk of supervised ketamine therapy in the United States today. Spravato is the only FDA-approved path; the rest are prescribed off-label, which is legal and common in U.S. medical practice. Typical costs below are based on HealingMaps’ 2026 review of 1,473 ketamine clinic locations.

Type	FDA Status	Route	Typical Cost (2026)	Insurance	Best For
Spravato (esketamine)	FDA-approved (2019, treatment-resistant depression)	Nasal spray	$0–$500/session copay; $600–$1,600 cash	Most PPO; some Medicaid	Treatment-resistant depression with insurance access
IV ketamine	Off-label	IV infusion	$400–$1,000/session; 6-session series $1,800–$6,000	Mostly self-pay	TRD, PTSD, chronic pain
IM ketamine	Off-label	Intramuscular injection	$200–$700/session	Self-pay	Cost-conscious patients seeking similar effects to IV
Oral / Lozenges	Off-label	Pills, troches, lozenges	$100–$500/month	Self-pay	Maintenance dosing; at-home telehealth protocols
KAP	Off-label	Any route + therapy	$300–$1,500/session	Self-pay	Patients wanting integrated talk therapy

Spravato (Esketamine): The FDA-Approved Path

Spravato is the brand name for esketamine, the S-enantiomer (one mirror-image molecule) of ketamine, delivered as a nasal spray. The FDA approved Spravato in March 2019 for treatment-resistant depression — depression that hasn’t responded to two or more standard antidepressants — and in August 2020 for major depressive disorder with acute suicidal ideation or behavior. Spravato is the only ketamine therapy with formal FDA approval for a mental health indication.

Because Spravato can produce sedation and dissociation, the FDA mandates a Risk Evaluation and Mitigation Strategy (REMS): patients must receive each dose at a certified clinic and remain under medical observation for two hours afterward. Patients cannot drive home; clinics typically arrange family pickup, ride-share, or supervised waiting rooms.

Insurance coverage is the primary practical reason patients choose Spravato over off-label IV ketamine. Most commercial PPO plans, many HMOs, and a growing number of Medicaid programs cover Spravato for treatment-resistant depression — typical out-of-pocket cost is $0–$500 per session as a copay, versus $400–$1,000 per IV ketamine session in cash for the off-label alternative.

Ketamine has a well-established clinical safety profile dating to its 1970 FDA approval as an anesthetic — more than 50 years of supervised use across operating rooms, emergency departments, and (since the early 2000s) mental health clinics. Therapeutic doses for depression, PTSD, and pain are substantially lower than anesthetic doses, and the FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression based on multiple Phase III trials. Serious adverse events are rare in supervised therapeutic settings; most patients experience only transient blood-pressure elevation and the dissociative state that’s central to the therapeutic effect. For deeper context on how ketamine clinics structure their pricing, protocols, and service mix, see HealingMaps’ 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 1,473 clinic locations across the U.S.

For a list of REMS-certified Spravato providers, see HealingMaps’ Spravato clinic directory. For detailed insurance and copay information, see Spravato cost in 2026 (with insurance).

IV, IM & Oral Ketamine: Off-Label Therapies

Three off-label formulations of racemic ketamine are commonly used for mental health and pain conditions. None are FDA-approved for these uses, but off-label prescribing is legal and common across U.S. medical practice when clinically appropriate.

IV ketamine

IV ketamine is the most studied and best-documented off-label protocol. Patients receive a low-dose infusion (typically 0.5 mg/kg over 40 minutes) in a clinical setting, with vital sign monitoring and post-treatment observation. In supervised clinical settings, IV ketamine onset is within minutes, with the dissociative phase lasting roughly 40–60 minutes. Most clinics use an induction series of 6 sessions over 2–3 weeks, followed by maintenance infusions every 2–8 weeks based on clinical response. IV ketamine is used for treatment-resistant depression, PTSD, chronic pain conditions (CRPS, fibromyalgia, neuropathy), and severe anxiety. For detailed cost and protocol breakdowns, see our IV ketamine cost guide and the ketamine dosage explainer.

IM ketamine

IM (intramuscular) ketamine delivers a similar dose via injection into a large muscle. Onset is faster than oral but slower than IV; effect duration is comparable to IV. IM ketamine is less common but offers a cost-conscious alternative — typically $200–$700 per session versus $400–$1,000 for IV.

Oral / Lozenge ketamine

Oral ketamine is dispensed as compounded pills, troches, or lozenges, typically for at-home maintenance dosing under telehealth supervision. Onset is slower (30–60 minutes) and effects build gradually. Oral protocols are well-suited for patients who have responded to in-clinic induction and are transitioning to maintenance, or for patients without practical access to in-clinic IV/IM administration. See our oral ketamine and lozenge guide for dosing context.

What Patients Experience During Ketamine Therapy

What patients experience during ketamine therapy depends largely on the dose and route. Lower clinical doses often produce a sense of calm, emotional release, or altered self-perception. Higher therapeutic doses commonly produce dissociation — a sensation of being separated from one’s body, normal sense of self, memories, and habitual thought patterns. During the dissociative phase patients remain mentally active — thinking, feeling, and remembering — but without the habitual emotional patterns and mental pathways that contribute to depression or PTSD. This break from established thought patterns is part of what allows ketamine therapy to produce rapid symptom improvement; some clinical research suggests that the depth of dissociation during treatment may correlate with subsequent symptom relief in depression. Most clinics now pair the in-session experience with a structured integration approach (post-treatment reflection, journaling, or therapy) to help patients process and apply insights from the session.

Ketamine-Assisted Psychotherapy (KAP)

Ketamine-Assisted Psychotherapy (KAP) pairs the ketamine experience with structured talk therapy. A licensed therapist is present (or available immediately after) for each dosing session and conducts pre-session preparation and post-session integration meetings. KAP is practiced under various protocols — the Polaris model, the Fluence model, and others — and can use any ketamine formulation (IV, IM, intranasal, sublingual) depending on the clinic’s setup.

KAP differs from the medical-model ketamine treatment described above in two key ways: (1) the dosing session itself is therapist-attended and frequently involves verbal interaction or guided imagery during the dissociative phase, rather than silent rest; (2) the integration sessions before and after dosing are central to the protocol, not optional. KAP is generally self-pay; sessions typically run $300–$1,500 each, longer than medical-model IV sessions because of the embedded therapy time.

For a deeper comparison of KAP vs medical-model ketamine therapy, see our ketamine-assisted therapy explainer.

Cost & Insurance Overview

Ketamine therapy costs vary widely by protocol, clinic, and city. Based on HealingMaps’ 2026 review of 1,473 ketamine clinics across the U.S.:

• Spravato (FDA-approved, esketamine): typically $0–$500 per session as a copay when insured; $600–$1,600 cash-pay. Most PPO plans cover Spravato for treatment-resistant depression.
• IV ketamine: $400–$1,000 per session (national typical $400–$700). Initial 6-session series typically $1,800–$6,000.
• IM ketamine: $200–$700 per session — cheaper than IV but less common.
• Oral / lozenges: $100–$500 per month. Most often dispensed via telehealth with maintenance dosing.
• KAP: $300–$1,500 per session including integrated therapy time.

Insurance coverage is the dividing line: Spravato is the only protocol routinely covered by commercial insurance; IV/IM/oral and KAP are predominantly self-pay. Cost-of-living drives price floors more than ceilings (concierge metros run 2–3× the national average).

For a city-by-city cost calculator and detailed insurance breakdown, see:

• Ketamine infusion cost: depression, pain, more
• Spravato cost in 2026 (with insurance)
• Does Tricare insurance cover ketamine therapy?

Is Ketamine Therapy Right for You?

Ketamine therapy is most commonly considered when:

• ✓ You have treatment-resistant depression (TRD) — depression that hasn’t responded to two or more standard antidepressant trials.
• ✓ You have PTSD or trauma-related anxiety where conventional psychotherapy and SSRIs haven’t been sufficient.
• ✓ You have chronic pain conditions (CRPS, fibromyalgia, neuropathy) poorly controlled by other medications.
• ✓ You can commit to in-person clinic visits (for IV/IM/Spravato) or a structured telehealth protocol (for oral/lozenge).
• ✓ You can afford either insurance copays (Spravato) or self-pay rates ($400–$1,000+ per IV session).

Ketamine therapy may not be the right fit if:

• ✗ You’re seeking a one-time “cure” — most protocols require an initial induction series (typically 4–6 sessions) plus maintenance.
• ✗ You have uncontrolled high blood pressure, recent heart attack/stroke, active psychosis, or active substance use disorder — these are relative or absolute contraindications.
• ✗ You’re seeking recreational use — this guide and HealingMaps’ clinical directory are not the right resource. Ketamine has medical applications when supervised; recreational use carries serious risks not covered here.
• ✗ Your only option is mail-order ketamine from unverified online sources — these are unsafe, often illegal, and not the same as clinic-supervised therapy.

This guide is informational. Whether ketamine therapy is right for any individual patient is a clinical decision made between you and a qualified prescriber.

Find a Ketamine Clinic

Looking for a ketamine therapy provider near you? HealingMaps maintains the largest editorial directory of verified ketamine clinics in the U.S. — including Spravato-certified providers, IV ketamine clinics, KAP practitioners, and hybrid in-clinic + telehealth options.

• Find ketamine clinics near you — searchable directory of 1,600+ verified clinics by city and state.
• Find a Spravato (esketamine) provider — REMS-certified clinics for the FDA-approved nasal-spray protocol.
• Best ketamine clinics by metro — editorial picks for major U.S. cities.

Related Guides

• Ketamine therapy types compared in detail — IV vs nasal spray vs lozenges with dosing context.
• Ketamine lozenges: dosage and what to expect — covers oral troche protocols.
• Ketamine dosage explained — what clinics actually give for IV, IM, nasal, oral.
• Ketamine-assisted therapy (KAT) explained — how KAT differs from KAP.
• Ketamine infusion cost: depression, pain, more — detailed cost breakdown.
• Spravato cost in 2026 (with insurance) — what insured patients actually pay.
• Where is ketamine legal? Country-by-country — international + state-by-state legal status.
• 2026 Ketamine Clinic Intelligence Report — proprietary analysis of 23,496 patient inquiries and 1,473 clinic locations.

Ketamine Therapy: FAQs

How long does ketamine therapy take to work?

Most patients feel some effect during their first session and report meaningful symptom relief within 1–2 weeks of starting an initial induction series (typically 4–6 sessions over 2–3 weeks). For depression and PTSD, response rates run 50–70% in clinical samples; for chronic pain, response is more variable.

Is ketamine therapy FDA-approved?

Spravato (esketamine nasal spray) was FDA-approved in 2019 for treatment-resistant depression and in 2020 for major depression with acute suicidal ideation or behavior. IV, IM, and oral ketamine are not FDA-approved for mental health indications — they are prescribed off-label, which is legal and common in U.S. medical practice.

Does insurance cover ketamine therapy?

Most commercial insurance plans (especially PPOs) cover Spravato for treatment-resistant depression. IV, IM, oral, and KAP ketamine are predominantly self-pay. Some clinics offer superbills patients can submit for partial out-of-network reimbursement; coverage varies widely by carrier and plan.

How much does ketamine therapy cost?

National typical costs (2026): Spravato copay $0–$500/session with insurance, $600–$1,600 cash-pay; IV ketamine $400–$1,000/session; IM ketamine $200–$700/session; oral/lozenges $100–$500/month; KAP $300–$1,500/session. Beverly Hills concierge clinics can run 2–3× the national average. See the Cost & Insurance Overview section above for the full breakdown.

Is ketamine therapy safe?

When administered in a supervised clinical setting at therapeutic doses, ketamine has a well-established safety profile dating to its 1970 FDA approval as an anesthetic. Common transient effects include blood-pressure elevation and dissociation (often expected/desired); rare bladder side effects can occur with chronic high-dose use. Ketamine therapy is not appropriate for patients with uncontrolled high blood pressure, recent cardiovascular events, active psychosis, or active substance use disorder.

Can I do ketamine therapy at home?

Some clinics offer at-home oral ketamine or lozenge protocols dispensed via telehealth, with virtual supervision and structured intake. In-clinic IV/IM/Spravato administration is more thoroughly monitored and is the standard for severe treatment-resistant cases. See our guide to oral ketamine and lozenge protocols for at-home pathway details.

What’s the difference between ketamine and Spravato?

Spravato is esketamine, the S-enantiomer (one of two mirror-image molecules) of ketamine, delivered as a nasal spray. It’s FDA-approved specifically for treatment-resistant depression and requires REMS protocol observation (2 hours after dosing) at certified clinics. Ketamine itself (used IV, IM, oral) is the racemic compound, prescribed off-label for the same and broader indications. Insurance coverage is the most practical day-to-day difference: Spravato is typically covered, ketamine generally isn’t.

How do I find a qualified ketamine clinic?

Look for clinics that (a) are run by or supervised by board-certified physicians (psychiatry, anesthesiology, pain medicine, or emergency medicine); (b) require an intake screening including medical and psychiatric history; (c) provide clear protocol documentation and pricing upfront; (d) offer in-person observation for IV/IM/Spravato administration; and (e) have follow-up integration support. Avoid clinics that offer ketamine without medical screening or that operate outside a supervised clinical model. For verified providers, see HealingMaps’ ketamine clinic directory.